Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Aquestive Therapeutics, Inc. (AQST Quick QuoteAQST - Free Report) : This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 72% over the last 60 days.

Aquestive Therapeutics, Inc. Price and Consensus

Aquestive Therapeutics, Inc. price-consensus-chart | Aquestive Therapeutics, Inc. Quote

Rubicon Technologies, Inc. : This cloud-based waste and recycling solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 69% over the last 60 days.

Rubicon Technologies, Inc. Price and Consensus

Rubicon Technologies, Inc. price-consensus-chart | Rubicon Technologies, Inc. Quote

Harpoon Therapeutics, Inc. : This immunotherapy company has seen the Zacks Consensus Estimate for its current year earnings increasing 64.2% over the last 60 days.

Harpoon Therapeutics, Inc. Price and Consensus

Harpoon Therapeutics, Inc. price-consensus-chart | Harpoon Therapeutics, Inc. Quote

Viad Corp : This leisure travel and events experience company has seen the Zacks Consensus Estimate for its current year earnings increasing 140% over the last 60 days.

Viad Corp Price and Consensus

Viad Corp price-consensus-chart | Viad Corp Quote

Avalo Therapeutics, Inc. (AVTX Quick QuoteAVTX - Free Report) : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 90.3% over the last 60 days.

Avalo Therapeutics, Inc. Price and Consensus

Avalo Therapeutics, Inc. price-consensus-chart | Avalo Therapeutics, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.